Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Journal of Pharmacology

• Publication date

  1998-09-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0014-2999(98)00546-9PMID 9774239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain dopamine transporter in spontaneously hypertensive rats.

  1997cited by this paper
• Effects of monosialoganglioside on a new model of tardive dyskinesia.

  1997cited by this paper
• Effects of age on a new animal model of tardive dyskinesia.

  1997cited by this paper
• A reanalysis of the dopamine theory of tardive dyskinesia: the hypothesis of dopamine D1/D2 imbalance

  1996cited by this paper
• Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia.

  1996cited by this paper
• Neuroleptic-Induced Movement Disorders: Neuroleptic treatment and tardive dyskinesia

  1996cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1995cited by this paper
• Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia

  1994cited by this paper
• The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats.

  1994cited by this paper
• Dopamine D1 and D2 receptors in the caudate nucleus of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats.

  1993cited by this paper
• Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis.

  1993cited by this paper
• Effect of SCH 23390 and quinpirole on novelty-induced grooming behaviour in spontaneously hypertensive rats and Wistar-Kyoto rats.

  1992cited by this paper
• Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density

  1992cited by this paper
• Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.

  1992cited by this paper
• Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.

  1991influential reference
• Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.

  1991influential reference
• Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.

  1990cited by this paper
• Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?

  1989cited by this paper
• Comparative studies of muscarinic and dopamine receptors in three strains of rat.

  1989cited by this paper
• Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat.

  1986cited by this paper
• Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats.

  1977cited by this paper

• Genetic effects in a progressive model of parkinsonism induced by reserpine

  2023cites this paper
• Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rat (SHR): implications for cognitive deficits in a progressive animal model for Parkinson's Disease.

  2021cites this paper
• Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson’s Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression

  2017cites this paper
• Assessment of Motor Function in Rodents: Behavioral Models Sharing Simplicity and Multifaceted Applicability

  2016cites this paper
• Rodent Model as Tools in Ethical Biomedical Research

  2016cites this paper
• Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.

  2011cites this paper
• Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?

  2009cites this paper
• Effect of Withania somnifera root extract on reserpine‐induced orofacial dyskinesia and cognitive dysfunction

  2006influential citation
• Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.

  2005cites this paper
• Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats.

  2005cites this paper
• Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.

  2004cites this paper
• Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia.

  2004cites this paper
• Decreased postsynaptic dopaminergic and cholinergic functions in the ventrolateral striatum of spontaneously hypertensive rat.

  2004cites this paper
• Reversal of Reserpine-Induced Orofacial Dyskinesia and Cognitive Dysfunction by Quercetin

  2004cites this paper
• Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.

  2003cites this paper
• Effects of valproic acid on an animal model of tardive dyskinesia.

  2003cites this paper
• Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice.

  2003cites this paper
• Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice.

  2002cites this paper
• Effects of melatonin on orofacial movements in rats

  2002cites this paper
• The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats.

  2002cites this paper